Clinical Report: B Cell Subpopulations in Pregnant Women After SARS-CoV-2 Vaccination

Overview

This study investigates the effects of SARS-CoV-2 vaccination and infection on B cell populations in pregnant women. Findings indicate significant alterations in B cell subpopulations and cytokine levels, highlighting the immunological adaptations during pregnancy.

Background

Understanding the immune response in pregnant women to SARS-CoV-2 is crucial due to their increased vulnerability to severe complications from respiratory infections. The balance between pro-inflammatory and anti-inflammatory B cell populations can influence maternal and fetal health outcomes. This research provides insights into how vaccination and infection may impact these immune dynamics.

Data Highlights

Key Findings

• SARS-CoV-2 vaccination significantly alters B cell populations in pregnant women.
• Infection increases IL-10+ B cells and decreases IL-6+ B cells compared to vaccinated women.
• Vaccination enhances expression of PD-1, FasL, and CD86 on B cells.
• Infection induces CD40 expression in B cells.
• Maternal cytokine levels vary based on vaccination and infection status.

Clinical Implications

Healthcare providers should consider the immunological changes in pregnant women following SARS-CoV-2 vaccination and infection when making clinical decisions. Monitoring B cell populations and cytokine levels may provide insights into maternal and fetal health.

Conclusion

The findings underscore the importance of understanding the immunological impact of SARS-CoV-2 on pregnant women, warranting further research into the long-term effects of maternal immunity on both mothers and their offspring.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022–April 2023 COVID-19 pandemic wave
2. Open Forum Infectious Diseases, 2021 -- Limited Cytokine Production in Infant CD4 T-Cell Responses Following SARS-CoV-2 mRNA Vaccination Influenced by Vaccine Manufacturer
3. The Journal of Infectious Diseases, 2021 -- Combined B-Cell and T-Cell Immune Responses Linked to Protection from Breakthrough Infections Following SARS-CoV-2 Vaccination in Participants of the Avon Longitudinal Study of Parents and Children (ALSPAC)
4. Blood Cancer Journal — Predictive Immune Biomarkers for Assessing SARS-CoV-2 Vaccine Efficacy in Individuals with Hematological Cancers
5. COVID-19 Vaccination for Women Who Are Pregnant or Breastfeeding | Covid | CDC
6. 2025–2026 COVID-19 Vaccination Guidance | Covid | CDC
7. SMFM Reaffirms COVID-19 Vaccination Recommendations During Pregnancy - Society for Maternal-Fetal Medicine
8. ACOG Releases Updated Maternal Immunization Guidance for COVID-19, Influenza, and RSV | ACOG
9. The Effectiveness and Influence of COVID-19 Vaccination on Perinatal Individuals and Their Newborns: An Updated Meta-Analysis - PMC
10. Safety of BNT162b2 COVID-19 Vaccine in Pregnancy: A Systematic Review - PubMed
11. SARS-CoV-2 Vaccination Before and During Pregnancy and Prevention of Infant COVID-19 Infection - PubMed
12. Single-cell mapping of peripheral immune dynamics in pregnant women after Moderna mRNA COVID-19 vaccination | Genes & Immunity
13. Immunogenicity and memory B-cell potency induced by an inactivated COVID-19 vaccine in pregnant women | Molecular Medicine | Springer Nature Link
14. Pregnancy Reduces COVID-19 Vaccine Immunity Against Novel Variants | medRxiv
15. Transplacental transfer of maternal SARS-CoV-2 antibodies in dichorionic and monochorionic twin pregnancies - PubMed